Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
Rhea-AI Summary
Positive
- None.
Negative
- None.
Details
Market reaction after 3Q26 earnings report: EMBC +26.29% in the Aug 7 session
In the Aug 7 session, EMBC gained 26.29%, reflecting a significant positive market reaction. Argus tracked a peak move of +28.8% during that session. Our momentum scanner triggered 88 alerts that day, indicating high trading interest and price volatility. Trading volume was very high at 4.8x the daily average, suggesting strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting period
- Q3 fiscal 2026
- Quarter covered by the announcement
- Employees
- approximately 2,000 employees
- Global company description
- Conference call time
- 8:00 a.m. ET
- August 7, 2026 investor conference call
- Webcast replay time
- 11:00 a.m. ET
- August 7, 2026 replay availability
- Replay archive period
- one year
- Investor relations website archive
Previous Earnings Reports
-
Quarterly results announcement was followed by a 57.84% negative 24-hour reaction.
-
Results announcement contained no quantified operating results, followed by a 7.75% decline.
-
Revenue pressure and initial fiscal 2026 guidance preceded a 7.24% negative reaction.
-
Strong revenue, earnings and guidance results preceded an 18.53% positive reaction.
-
Revenue decline and lowered revenue guidance preceded a 10.00% negative reaction.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported third quarter fiscal 2026 financial results.
Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed third quarter fiscal 2026 earnings press release and investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, Aug 7, 2026, which is accessible here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on Aug 7, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
